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Unbiased, label-free proteomics is becoming a powerful technique
for measuring protein expression in almost any biological sample.
The output of these measurements after preprocessing is a collec-
tion of features and their associated intensities for each sample. Sub-
sets of features within the data are from the same peptide, subsets
of peptides are from the same protein, and subsets of proteins are
in the same biological pathways, therefore, there is the potential
for very complex and informative correlational structure inherent in
these data. Recent attempts to utilize this data often focus on the
identification of single features that are associated with a particu-
lar phenotype that is relevant to the experiment. However, to date,
there have been no published approaches that directly model what we
know to be multiple different levels of correlation structure. Here we
present a hierarchical Bayesian model which is specifically designed to
model such correlation structure in unbiased, label-free proteomics.
This model utilizes partial identification information from peptide
sequencing and database lookup as well as the observed correlation
in the data to appropriately compress features into latent proteins
and to estimate their correlation structure. We demonstrate the ef-
fectiveness of the model using artificial/benchmark data and in the
context of a series of proteomics measurements of blood plasma from
a collection of volunteers who were infected with two different strains
of viral influenza.
1. Introduction. Unbiased, label-free, mass spectrometry proteomics,
sometimes called “shotgun” proteomics, is a technique for measuring nearly
all abundant proteins in a biological sample. Because of numerous technical
advances it is becoming increasingly robust and sensitive, leading to greater
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effectiveness for the study of biological and medical questions [Aebersold and
Mann (2003), Service (2008), Ping (2009)]. While early work in this field met
with a number of notorious failures [Petricoin et al. (2002), Baggerly et al.
(2004), Zhang and Chan (2005)] due to overlapping peaks, batch effects
and systematic noise, high accuracy spectrometers along with multiple frac-
tionation techniques such as liquid chromatography and ion mobility have
led to increased robustness as well as improved qualitative and quantitative
results.
After summarization, data generated by this technology is typically pre-
sented as a p × n dimensional matrix of real-valued intensities where the
number of measured features p is typically orders of magnitude larger than
n, as in microarray gene expression data. However, there are a number of im-
portant characteristics that distinguish mass spectrometry proteomics from
gene expression data. First, each feature is a short peptide that has been
enzymatically cut out of a parent protein, and parent proteins typically give
rise to many such peptides. Second, only the more abundant of these features
are typically identified (meaning that the peptide sequence and originating
protein are known). Third, features that are present at lower abundances will
typically have numerous missing values across the samples. Finally, while the
error rate for assigning identifications to features is low, it is not zero, and
this leads to some peptides with incorrect identifications.
Analysis approaches for these data can be performed at the feature level
or at the protein level. The obvious consequence of performing analysis at
the feature level is a significant loss of power due to the highly dependent
nature of subsets of the features—particularly those that originate from the
same protein. We prefer a dimension reduction approach in which groups of
features are collected and summarized prior to analysis of associations be-
tween features and biological phenotypes. There are a number of approaches
to this in the literature, almost all of which rely entirely on the identified
features in the data set.
The simplest of these approaches involves direct summarization of all or
some features that are identified for each protein either through averaging
or robust summarization based on quantiles [Polpitiya et al. (2008)]. There
are also a number of regression approaches which include fixed effects for
protein, peptide and experimental group [Karpievitch et al. (2009)], include
an additional random effect for situations in which subjects are measured in
replicate [Daly et al. (2008)], or add additional interaction effects between
treatment and features [Clough et al. (2009)]. These may assume constant
or varying noise levels across isotope groups and have been shown in some
cases to exhibit better performance than naive summarization approaches
that do not adjust for confounding factors [Clough et al. (2009)].
We are aware of only one approach to the analysis of these data that
examines correlation structure between data features [Lucas et al. (2012)].
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This approach utilizes a latent factor model to aggregate features and uses
priors on the loadings that are informed by identifications. This leads to
aggregation of multiple features into “metaproteins.” This is a sparse factor
modeling approach where nonzero loadings for factor i are biased toward
features that are identified as originating from protein i. While this approach
allows the utilization of unidentified features in the data, it fails to account
for correlation structure that arises when multiple proteins are involved in
the same pathways.
In this paper we present an extension of Lucas et al. (2012) that explic-
itly models correlation structure between factors. We do this by incorporat-
ing a hierarchical structure on the latent metaproteins that allows borrow-
ing strength between factors to estimate overall factor scores. We demon-
strate improvements over both a generic sparse factor model [Carvalho et al.
(2008)] and the earlier proteomics factor model [Lucas et al. (2012)], in terms
of accuracy of factor estimates and eventual association with biological phe-
notypes. Finally, we demonstrate the incorporation of known correlation
structure in the form of time series measurements in our analysis of a viral
challenge data set in Section 7.
2. Motivating data. While the specifics of data generation may vary at
different proteomics laboratories, the model we describe is appropriate for
any high-accuracy mass spectrometry data. In general, the steps to data
generation are as follows: (i) a biological sample is distilled to a solution
containing those proteins that are of interest; (ii) the proteins in the sample
are then broken up via trypsin; (iii) the processed sample is separated ac-
cording to hydrophobicity using liquid chromatography. The time at which
a particular constituent of the sample passes out of the chromatography
column is called the retention time; (iv) an electric charge is induced on
the peptides; (v) the mass and intensity of these ions is measured in a mass
analyzer. The intensity and ion masses are measured at a regular interval,
called the sampling rate, and the resulting measurements form a trace with
visible peaks, called features, that correspond to one or more peptides. Be-
cause the sampling rates are high relative to the size of these features, each
feature spans a range of mass-to-charge ratios and retention times.
In nature, approximately 1% of all Carbon atoms are Carbon-13 (they
contain an extra neutron). This leads to multiple features per peptide, each
one containing a different integer number of Carbon-13 atoms. These are col-
lected into a single isotope group (IG) during preprocessing, and the intensity
of this isotope group is estimated as the total volume under its associated
features. In addition to multiple features from Carbon-13 substitution, a
peptide may be present in the data set multiple times at different charge
states. These different charge states will have different mass to charge ratios
and therefore result in multiple isotope groups per peptide.
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There are inherently two different types of correlation present in label-
free, unbiased proteomics data. First, each isotope group originates from a
particular protein and there are typically many isotope groups per protein
in the data set—particularly for proteins that are highly abundant and/or
of large molecular weight in the original sample. Second, some collections
of proteins are expected to behave similarly because they are part of the
same biological pathways. This will result in correlation between proteins
(and therefore correlation between isotope groups) that are of distinct etiol-
ogy. In general, distinct sources of correlation are confounding without some
additional information allowing us to distinguish them. In the case of pro-
teomics, there are techniques for identifying the specific amino acid sequence
of a subset of the isotope groups that are present at relatively high concen-
trations. These sequences are then associated to particular proteins through
sequence alignment to proteins in a database [Nesvizhskii et al. (2003)]. We
have then, for a limited subset of the isotope groups, a (possibly imperfect)
peptide sequence and originating protein, which we call an annotation.
The proteomics data we will be focused on was obtained from 43 pa-
tients as part of the DARPA H1N1/H3N2 viral challenge project [Zaas et al.
(2009)]. From the entire pool, 24 patients were exposed to H1N1 and 17 were
exposed to H3N2. For each patient, four samples were taken at different ref-
erence time points, baseline (t= 0), the time of maximum symptoms (t= 1)
as well as t= 0.2 and t= 0.8. Each subject was labeled as symptomatic (SX)
or asymptotic (ASX) based on self-reported symptom scores, as well as viral
culture. The samples of the H3N2 study were run in two batches with the ini-
tial pilot study containing only samples from time points t= {0,1} and the
followup containing the t= {0.2,0.8} samples. In summary, we have N = 172
samples from two studies (H1N1 and H3N2) divided in three batches (H1N1,
H3N21 and H3N22), two conditions (SX and ASX) where fortunately the
batches and conditions are not confounded. The data itself is a matrix con-
taining expression values for approximately 40,000 different IGs. Peptide
annotation was done using a combination of Mascot and PeptideProphet al-
gorithms [Keller et al. (2002), Perkins et al. (1999)]. Nearly 85% of the IGs
remained unannotated. Since H1N1 and H3N2 are two different experiments,
their annotation set is substantially different, thus, an alignment algorithm
must be used in order to take advantage of as much annotated data as pos-
sible, otherwise we will be forced to use only those IGs shared by both data
sets (1697 IGs). Isotope groups from the three batches were aligned using
the algorithm described in Lucas et al. (2012). From all IGs, 13,845 were
successfully aligned across the H1N1 and H3N2 data sets. From the set of
4670 annotated IGs, only 1697 had annotations in both data sets. The set
of annotations consists of 239 proteins from which 106 are assigned to more
than one IG. The data has a relatively low overall missingness rate, most
of them among low abundance IGs. However, missing values are unevenly
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distributed: H3N21 having 10.3% missingness, H3N22 0.7% and H1N1 up
to 2.5%. Two samples were removed from subsequent analysis because they
had more than 30% missing values in the set of annotated IGs.
3. Model definition. We model a sample n of batch m consisting of p
IG expressions, xmn , as an extended factor model separated into four effects,
namely, batch, systematic, protein expression and noise,
x
m
n =µ
m +Azn +Bwn + εn,(3.1)
where xmn , µ
m, zn, wn and εn are p× 1 vectors. In particular, µ
m is the
mean expression vector of batch m, factors zn = [z1n · · · zNF n]
⊤ are meant
to capture NF systematic effects, wn is the expression level of NP proteins
for sample n, A and B are p × NF and p × NP loading matrices for the
systematic effects and protein expressions, respectively, and εn is measure-
ment idiosyncratic noise. Systematic effects are included in the model for
the sole purpose of cleaning the data as much as possible from batch effect
specific and technical noise, with the aim to obtain protein profiles {wn},
that better reflect true biology rather than technical variability. Provided
that protein expression is not directly observed and because profile vectors
[wk1 · · · wkN ] are likely to be estimated from IGs that belong to multiple
proteins, from now on we refer to them as latent proteins. A priori, we let
each IG be associated only to a single latent protein, say, k, meaning that
each row of B contains just one nonzero entry.
Identifiability issues in the model of (3.1) are minimized for three reasons:
(i) confounding between systematic effects and metaproteins is very unlikely
because A is dense and B is highly sparse. (ii) wn does not have a sign
ambiguity because B has only nonnegative entries. (iii) zn can be identified
up to scale and permutations as long as its distribution is non-Gaussian [see
Kagan, Linnik and Rao (1973)]. Scale and permutation ambiguities are not
of great concern here because we are not interested in the interpretation of
systematic effects. Besides, in a case in which batch effects fully correlate
with biological effects, our model will model them jointly as batch effects.
This type of batch confounding is reasonably common in high-throughput
data [Leek et al. (2010)], and the failure of our model to find biological
effects when those effects are heavily confounded with batch is the desired
behavior.
3.1. Prior specification. We need to specify prior distributions for each
one of the elements in the right-hand side of (3.1). Measurement noise is set
to a zero-mean Gaussian with diagonal covariance matrix Ψ, to allow for
different noise variances for each IG. Entry specific priors for Ψ are set to
flat inverse gamma distributions with shape ts = 1.1 and rate tr = 0.001, the
former to keep the variance bounded away from zero. Mean batch effects
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have Gaussian priors with mean tm = 8 and small precision tp = 0.01, set
mainly based on the overall mean expression of the data. Missing values are
provided with independent standardized Gaussian distributions in order to
favor small values. This reflects the fact that missing values are mostly due
to low abundance peptides.
3.1.1. Systematic effects. We define systematic effect as a portion of vari-
ability expressed in a large collection of isotope groups that cannot be classi-
fied either as nonspecific measurement noise or biological variability, mean-
ing that it is more likely due to technical variability. These effects are usually
characterized by high levels of correlation across many isotope groups, but
potentially only in a subset of the samples (e.g., only those in one batch).
We capture the first part through the use of independent Gaussian priors
on the elements of A, which allows systematic effects to span the entire set
of isotope groups. Aiming to allow individual samples to be largely dropped
from specific systematic factors, we utilize independent Laplace priors for
the elements of zn. These are parameterized as scale mixtures of Gaussians
with exponential mixing densities to facilitate inference [Henao and Winther
(2011)]. We consider that the number of systematic factors NF is not crit-
ical because we are not concerned about the interpretability of matrix A.
Besides, we have observed empirically that the variance explained by the
systematic effect factors saturates quickly as NF increases. However, we de-
cided to place an automatic relevance determination (ARD) prior onA [Neal
(1996)]. In particular, being aij and zjn elements of A and zn, respectively,
we have
aij ∼N (0, ρ
−1
j ), ρj ∼Gamma(rr, rs),
zjn ∼N (0, τjn), τjn ∼ Exponential(λ
2), λ2 ∼Gamma(ℓs, ℓr),
where ρj is a shared factor-wise variance for the columns of A and τjn is an
auxiliary variance with exponential mixing so, marginally, zjn ∼ Laplace(λ
2)
[Andrews and Mallows (1974)]. We further place a gamma hyperprior on the
rate of the Laplace distribution with parameters ℓs = 4 and ℓr = 2. The ARD
is a variable selection prior; Large values of ρj will correspond to small values
of the jth column of A, thus virtually switching off the entire effect. Setting
rr = 1.1 and rs = 0.001 will encourage the desired behavior. In practice, the
effective number of factors can be determined by thresholding ρj or the
elements of A column-wise.
3.1.2. Latent protein profiles. We make two assumptions regarding iso-
tope group expression. One is that each isotope group originates from only
one latent protein and the other is that latent proteins may correlate with
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Fig. 1. Latent protein tree structure. Particular tree with NP = 5 and three isotope groups
assigned to each latent protein. The pseudo time variable t defines the merging points.
each other due to biological pathway activity. To model the first feature, we
set a prior hierarchy as follows:
bi,ui |ui ∼N+(0,1), ui|vi ∼Discrete(vi), vi|α∼Dirichlet(α1NP ),
where bi,j = 0 if j 6= ui, N+(·) is the Gaussian distribution truncated below
zero and where the ith IG is associated with the latent protein indexed by ui
with probability vi. This means that vector u serves as a labeling variable
for IGs. The conjugate prior for the vector of NP probabilities, vi, is set
using a shared concentration α. For the latter, we provide a flat gamma
prior with parameters as = 1 and ar = 1 [see Escobar and West (1995)].
We know that groups of proteins might have similar expression profiles
for different reasons, for example, because they are structurally similar, me-
diate similar biological processes, share a pathway, etc. In order to capture
this structure, we place a prior over binary trees on the NP latent pro-
teins. This allows us to model correlation among metaproteins and leads to
an interpretable representation of isotope groups, latent proteins and their
interactions. Figure 1 illustrates the concept for a particular setting with
p = 15 IGs distributed in NP = 5 proteins. We can see a hierarchical clus-
tering structure in which, for instance, latent proteins w1 and w2 are more
similar than w4 and w5, thus more correlated. The pseudo time tj at which
two nodes merge into vj acts as a similarity measure so that more alike latent
proteins merge sooner in time, allowing us to directly quantify their pair-
wise or group-wise similarities. The proposed hierarchy is an implementation
of the Kingman’s coalescent [Kingman (1982a)] and reflects the idea that
isotope groups and latent proteins lay in different levels and that protein
pathways are proxies for the average profiles of collections of proteins.
Given a tree structure, {t,pi}, where t is the vector of merging times and
pi is the set of partitions at each level of the tree, we specify the relation-
ship between node vj and its parent node nk (or wk at the leaves) through
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a multivariate Gaussian transition probability and set the following prior
hierarchy:
vj |vk, tj, tk,Φ∼N (vk, (tk − tj)Φ), {t,pi} ∼Coalescent(Np),(3.2)
where vj is a N -dimensional row vector and Φ is a covariance matrix en-
coding the correlation structure in vj . A coalescent prior selects a pair to
merge uniformly from partition πj and sets merging times with rate 1, this
is tk ∼ Exponential(1). With no further constraints, this prior distribution
leads to a uniform prior distribution over trees that is independent of merg-
ing times and is infinitely exchangeable [Kingman (1982a, 1982b)]. Different
priors for Φ add flexibility to the model, for example, in the i.i.d. case,
a diagonal Φ with independent inverse gamma prior distributions on each
diagonal element will accommodate for differing levels of noise for different
samples. In cases where there is known structure, a different prior could be
used. In our analyses we use inverse Wishart priors to model correlation
due to sample replicates and Gaussian process priors for smoothness in time
series data. Inference for hierarchy in (3.2) is carried out using an efficient
sequential Monte Carlo Sampler introduced by Henao and Lucas (2012).
3.2. Inference. Model fitting is performed using Markov chain Monte
Carlo (MCMC) to collect samples from the posterior of all parameters in
the model, namely, µm, A, zn, B, wn, Ψ, u, pi and Φ. The most relevant
summaries involve posterior samples from the latent proteins, IG-protein
assignments and the hierarchical structure encoded by the binary tree, pi.
Nearly all quantities of interest are updated using Gibbs sampling except for
the tree components that require sequential Monte Carlo (SMC) sampling.
In all the experiments described in this paper we set the hyperparameters
of the model to the values already mentioned unless otherwise stated. The
upper bound for the number of factors is set to a conservatively large value;
we have observed in practice that NF = ⌊2 log(p)⌋ is large enough. For tasks
with p and N in the lower thousands and hundreds, respectively, we can
expect the inference routine to take less than a couple of hours in a desktop
machine. The entire sampling sequence is fully described in the Appendix.
Summaries for most of the important quantities of the model are com-
puted in the usual way by means of histograms and empirical quantiles.
Summarizing trees, on the other hand, is not such an easy task because
tree averaging is not a well-defined operation. We could, in principle, use
the pseudo time variable to build a pairwise distance matrix between latent
proteins and then attempt to build a tree from a summary of such a simi-
larity matrix. The problem being that we do not have any guarantee that
this average of binary trees will produce a binary tree as well. We tried this
approach with both artificial and real data, and found that the tree built
using means or medians of the similarity matrices collected during inference
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oftentimes produced trees with nonbinary branching, thus not matching the
prior assumption. In view of this, we decided to select a single tree from
all the available samples using as criterion the marginal likelihood of the
tree. This is a common practice in tree based models; see, for instance, Teh,
Daume III and Roy (2008) and Adams, Ghahramani and Jordan (2010).
The source code and demo scripts for the model presented in this paper
are written in MATLAB and C, and have been made publicly available at
http://www.duke.edu/~rh137/files/lpt_v0.3.tar.gz.
4. Artificial data. We begin with a set of experiments using artificially
generated data in order to illustrate some of the features of our model and to
perform some quantitative comparisons. We generated two data sets D1 and
D2 of sizes {p,N,NB ,NF ,NP } = {800,80,2,4,32} and {1600,80,3,6,64},
respectively. Denoting the elements of µm, A, B and Ψ as µmi , aij , bik and
ψi, respectively, we draw N observations of the model from the following
hierarchy:
x
m
n ∼N (µ
m,Σ),
µmi ∼N (8,2), m∼Discrete(N
−1
B 1NB ),
aij ∼N (0,0.1),
bi,ui ∼N+(0,1), ui ∼Discrete(v),
ψ−1i ∼Gamma(1.1,0.02), v∼Dirichlet(α),
S
−1 ∼Wishart(I,NP ), α∼Uniform(0.8,2.4),
where Σ=AA⊤ +BSB⊤ +Ψ, A is a p×NF matrix of systematic factor
loadings, B is a p×NP matrix of latent protein loadings, S is the covariance
matrix of the latent protein profiles and Ψ is the noise diagonal covariance
matrix, as in (3.1). We generated 50 replicates of each data set and uniformly
flagged 20% of its values as missing. We ran our sampler for 4000 iterations,
using the first 3000 as burn-in period. For this experiment, we set the distri-
bution of the systematic factors to Gaussian, to match the assumption made
in Σ. Since we are not introducing correlation across samples, we set Φ to
diagonal with independent gamma priors. The average number of system-
atic factors is selected with threshold ρj < 10
3. We label each latent protein
by tabulating the IGs associated to it from vector u and then picking the
label having maximum count. We define identity as the percent of correctly
labeled latent proteins and confusion as the percent of variables incorrectly
associated to their latent proteins. We compare our model (LPT) with (i)
its simplified version without the tree structure inference we call sLPT, thus
without covariance structure in the latent profiles [Lucas et al. (2012)]. Ta-
ble 1 shows results for the structural components of the model—identity,
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Table 1
Structural measures for artificial data. NF is selected with threshold
ρj < 10
3. Pairs in brackets are empirical 90% intervals across replicates.
Best results in boldface letters
Set Method NF Identity Confusion
D1 LPT 4 (3,7) 0.97 (0.94,1.00) 0.002 (0.000,0.009)
sLPT 4 (3,7) 0.97 (0.91,1.00) 0.005 (0.000,0.016)
D2 LPT 6 (5,10) 0.98 (0.97,1.00) 0.003 (0.00,0.008)
sLPT 6 (5,10) 0.97 (0.93,1.00) 0.007 (0.001,0.014)
confusion and number of systematic factors. Results demonstrate that the
model is able to capture the association between IGs and latent protein pro-
files through u while properly handling “batch” effects and missingness in
the data. The two methods perform similarly because estimates of system-
atic effects and peptide-protein associations is only weakly influenced by the
protein tree structure. Even so, LPT performs slightly better than sLPT in
terms of protein association accuracy.
We can also assess the performance of our model in terms of covariance
matrix and missing value estimation. We compare LPT and sLPT as well as
a sparse factor model as proposed by Carvalho et al. (2008), sFM, which uti-
lizes the same priors for missing values and batch effects used by our model.
For sFM we set the number of factors to NF +NP = {21,24}, accordingly.
In principle, the sparse model is flexible enough to estimate A and B but
not S, for the model assumes independent profiles, similar to sLPT. Table 2
shows summaries of mean square error (mse), mean absolute error (mae)
and maximum absolute bias (mab) across replicates for the methods under
consideration. As seen in Table 2, our model performs better than the other
two alternatives. In particular, we see that sLPT and LPT behave similarly
in terms of missing value estimation, however, LPT significantly outperforms
the others in terms of covariance matrix estimation, as the model explicitly
accounts for it. Significance is measured in terms of median mse, mae and
mab pairwise differences with p-value threshold 0.01.
The entire experiment was repeated for small variations in the hyperpa-
rameters of the models and the artificial data generator without considerable
changes in the results. In general terms, we observed good mixing in the sam-
pler using exploratory and standard diagnostic tests. We also repeated the
experiment with correlation across samples and an inverse Wishart distri-
bution for the matrix Φ with results similar to those in Tables 1 and 2.
5. Confounding due to batches. Next we explore how different levels of
confounding between biological and batch effects impact results. For this
purpose, we generated 50 replicates of a modified version of data sets D1
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Table 2
Performance measures for artificial data. sLPT is the simplified LPT and sFM is a
sparse factor model. mse, mae and 10−1×mab are mean squared error, mean absolute
error and maximum absolute bias, respectively. Pairs in brackets are empirical 90%
intervals. Best results shown in boldface letters. Differences in covariance measures
between LPT and sLP are significant with p-value threshold 0.01
Set Measure LPT sLPT sFM
Covariance
D1 mse 1.291 (0.898,1.678) 4.538 (2.813,7.738) 4.776 (3.029,7.673)
mae 0.883 (0.748,1.016) 1.472 (1.217,1.922) 1.396 (1.179,1.874)
mab 0.753 (0.532,2.287) 1.204 (0.939,2.454) 1.473 (1.176,7.703)
D2 mse 1.143 (0.978,1.525) 2.439 (1.922,3.381) 2.434 (2.018,3.683)
mae 0.840 (0.787,0.946) 1.079 (0.974,1.286) 1.001 (0.865,1.182)
mab 0.848 (0.636,4.844) 1.161 (0.996,4.958) 1.658 (1.163,8.871)
Missing values
D1 mse 0.144 (0.083,0.352) 0.150 (0.088,0.376) 1.935 (1.221,2.514)
mae 0.193 (0.178,0.215) 0.195 (0.179,0.212) 0.690 (0.536,0.845)
mab 0.850 (0.473,2.908) 0.890 (0.586,2.902) 1.096 (0.939,2.347)
D2 mse 0.146 (0.110,0.367) 0.148 (0.105,0.341) 2.345 (1.894,2.933)
mae 0.193 (0.184,0.211) 0.194 (0.184,0.213) 0.784 (0.679,0.913)
mab 1.102 (0.724,2.936) 1.018 (0.727,2.426) 1.200 (1.040,2.537)
and D2 from a previous experiment in which we set NB = 2 and added 2
biological effects as follows:
w1n,w2n ∼N (µe,1), wkn ∼N (0,1),
where µe = 0.75 or µe =−0.75 if sample n has a positive or negative biolog-
ical effect, respectively, and k = 3, . . . ,{32,64}. Batch indicators are drawn
uniformly, but biological effect indicators are obtained such that a proportion
(τ ) of samples share both indicators. When τ = 0.5 the overlap is minimum
and when τ = 1 batch and biological effects are fully confounded, as both
can be jointly captured as batch means. For the results, we computed the
proportion of times our model found 0, 1, 2 (ground truth) true positives
and 1, 2, etc. false positives. Biological effects are tested for on each protein
using t-tests with p-value threshold 0.01 and Bonferroni correction for the
number of proteins. Figure 2(a) shows that for the minimum overlap our
model finds the 2 biological effects approximately 90% of the times and that
such a proportion decreases to exactly zero (100% 0 true positives) as the τ
approaches 1. We also see that the false positive rate is very small and that
for large overlaps is always zero. As the model is currently defined, any effect
that correlates with batch indicators will be treated as a batch effect, in that
sense, confounded biological effects cannot—and arguably should not—be
detected.
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Fig. 2. Confounding effects results for D1 (a) and D2 (b). Each marker represents the
proportion of replicates (50) for which our model found 0, 1, 2 (ground truth) positives
and false positives. Mind that rates for true positives sum up to 1.
6. Spike-in data. The benchmark data set originally introduced by Mueller
et al. (2007) consists of 6 samples measured in three replicates. Each sample
is a mixture of six nonhuman purified proteins in different concentration lev-
els spanning two orders of magnitude from 25 to 800 fmol. Figure 3(a) shows,
in dashed lines, ground truth concentrations on a log-scale and scaled to fit
in the interval [0,1]. The raw data containing approximately 15,900 IGs per
sample was filtered down to 1841 IGs per sample after identification, anno-
tation and exclusion of unidentified IGs with 50% missing values or with less
than 10% of the maximum variance IG. Annotations are available for only 88
IGs; This is 4.7% of the set. The final data set contains 18 observations and
1841 IGs labeled with 7 protein names, ADH1-Y (12), ALDOA-R (20), CAH2-B
(13), CYC-H (24), LYSC-C (9), MYG-H (10) and UKN (1753), with the num-
ber of IGs per protein in parentheses and UKN denoting unannotated IGs.
Fig. 3. Spike-in data profiles. (a) Ground truth (dashed) and estimated (solid) protein
profiles scaled between 0 and 1. Replicates are shown as markers and solid lines are averages
across replicates. (b) Median IG expression grouped according to the labeling obtained
during inference and averaged across replicates. Dashed lines correspond to original data
with missing values and solid lines to data with missing values replaced by their estimates.
Credible intervals were omitted for clarity.
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The data matrix has a missingness of 30% that is more or less evenly dis-
tributed across observations. The original experiment reported by Mueller
et al. (2007) only uses annotated data. Since the data set is relatively clean
and all the samples were obtained in a single session, we do not expect sys-
tematic, batch effects or a meaningful covariance structure. However, we do
expect high correlation due to replicates, thus, we provide Φ with an inverse
Wishart prior with 10×N degrees of freedom and scale matrix composed
of 6 blocks of magnitude 0.9 and size 3 plus 0.1 times the identity matrix.
Although learning the degrees of freedom and the blocks/diagonal propor-
tions will be more principled, we did not observe substantial changes in the
results from small changes in the previously mentioned values. We ran the
sampler for 4000 iterations with a burin-in period of 2000.
Figure 3(a) shows the summary of the estimated latent protein profiles.
Each circle represents a replicate, solid lines are averages across replicates
and dashed lines represent the ground truth [see Mueller et al. (2007)]. Sum-
maries were computed using medians and credible intervals were omitted for
clarity. Summaries with credible intervals are available as the supplementary
material [Henao et al. (2013c)]. Compared to the ground truth, our model
does a pretty good job at capturing the underlying profiles of all 6 proteins
of interest despite the large amount of missing values and unannotated IGs
used.
Availability of the true protein profiles allows us to quantitatively evaluate
how accurate our model is at estimating the protein profiles. We compare
four different models: (i) the model for protein quantitation described in
Karpievitch et al. (2009) where we have used protein concentrations as a
grouping variable (Karp09) and three variants of our model, (ii) full i.i.d. la-
tent proteins, meaning no tree structure prior; (iii) independent gamma dis-
tributions and diagonal Φ, assumes no correlation due to replicates and (iv)
inverse Wishart prior for Φ with scale matrix as already described. Results
of model (iii) also appear in Henao et al. (2012). Although the three fac-
tor models [(ii)–(iv)] produce profiles similar to those shown in Figure 3(a),
there are small differences. Table 3 indicates that in terms of mse, mae and
mab, the results of the model with the inverse Wishart prior (iv) are most
accurate. Although the covariance structure in the true protein profiles is
not interpretable in this experiment, they are correlated, which explains why
the two models with tree structure prior [(iii) and (iv)] outperform the full
i.i.d. models [(i) and (ii)]. Additionally, the inverse Wishart prior in model
(iv) is improved over model (iii) because the prior accounts for the sample
correlation resulting from having replicates in the experiment.
We can use the labeling vector u to examine how unannotated isotope
groups were labeled after inference. In particular, ADH1-Y went from having
12 IGs to 118, ALDOA-R from 20 to 307, CAH2-B from 13 to 240, CYC-H from
24 to 288, LYSC-C from 9 to 189 and MYG from 10 to 185. Figure 3(b) shows
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Table 3
Performance measures for spike-in data. mse, mae and mab are
mean squared error, mean absolute error and maximum absolute
bias, respectively
Tree with Φ prior
Measure Karp09 No tree Indep. gamma Inverse Wishart
103 ×mse 12.370 2.524 1.899 1.661
102 ×mae 6.915 3.172 2.983 2.494
101 ×mab 3.094 1.443 1.252 1.213
median IG expression grouped according to the labeling vector u and aver-
aged across replicates to make easier comparisons against the ground truth
in Figure 3(a). Dashed and solid lines correspond to data with and without
missing values, respectively. For the latter, we have replaced the missing
values with those estimated by our model. We see that for every protein
our model estimates of missing values improve the expression average. The
largest improvement is in the lower end of the expression range, precisely
where the missing values are likely to be found [see Mueller et al. (2007)].
A similar picture using only the labeling from annotation does not resemble
the ground truth at all. This is because the original labeling only comprises
88 IGs with a considerable amount of missing values.
7. H1N1/H3N2 viral challenge. We present now the case study based
on the motivating data already described in Section 2. Here we will be using
only the set of 4670 annotated IGs for which we have at least 2 IG per
protein. Therefore, for this study we have n = 172, NB = 3, NF = 16 and
NP = 106. Additionally, each observation can be seen as an element of a
time series of length 4, that is, t = {0,0.2,0.8,1}. If we let latent proteins
have Gaussian process priors with squared exponential covariance function
and assuming no sample correlation across patients, we can compute the
entries of Φ from
φ(i, j) = cij exp(−ℓ
−1d2ij) + σ
2δij ,
where ℓ is the inverse length scale, σ2 the idiosyncratic noise variance, δij = 1
only if i = j, cij = 1 only if samples i and j are from the same patient,
and dij = ti − tj is the time difference between pair {ti, tj} ∈ {0,0.2,0.8,1}.
Hyperparameters ℓ and σ2 are updated using slice sampling [Neal (2003)].
We ran the inference procedure for 5000 burn-in iterations followed by 2000
samples to compute summaries. The whole procedure takes approximately
2.5 hours in a regular desktop machine with 4 cores. Mixing was monitored
using both exploratory and standard diagnostic tests. Table 4 reports the
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Table 4
Structural measures for viral challenge data. NF is
selected with threshold ρj < 10
3 and stability with
threshold 0.6
NF Identity Confusion Stability Unique
3 0.774 0.511 0.958 0.783
resulting structural components of the model, namely, previously described:
number of systematic factors, NF , identity and confusion. We define stability
as the proportion of IGs having a single value in the label vector u for at
least 60% of the MCMC samples after the burn-in period. We also define
unique as the proportion of latent proteins with distinct labels.
7.1. Consistency with annotation. From Table 4 we see that approxi-
mately half of the IGs ended up with a protein label different from their
annotation (confusion). Possible explanations for this include systematic ef-
fects, post-translational modifications, measurement error and alignment in-
duced mislabeling. In this example, consider the problem of aligning batches
H1N1, N3N21 and N3N22. Initially, the three batches have different sets of
annotation that need to be matched to create a common annotation set.
We use the alignment algorithm described in Lucas et al. (2012). From the
4670 IGs included in the model, annotation was transferred from one of the
batches to the other two in 64% of the cases. This means that more than
half of the IGs are more prone to miss-annotation due to the challenges of
aligning between data sets. We found that a disproportionate percentage of
peptides that retained their label from annotation after model fit are from
the set of IGs with H1N1/H3N2 shared annotation. This suggests that IGs
annotated simultaneously in all sets tend to be more reliable than those
labeled by label transfer.
The identity of the model, on the other hand, indicates that 82 latent
proteins match annotation when labeled by consensus of their IG members.
The remaining latent proteins represent cases of duplicate representation of
particular proteins. For example, there are 6 latent proteins associated with
APOB-H (the most commonly identified protein in the data), all of them with
disparate profiles. Figure 4(a) shows the composition of all latent proteins.
For each latent protein (column), we tabulate and sort the labels of its
IG members (rows). Darker colors represent proportions closer to 1. The
first row is used to compute the consensus to determine identity. The red
bar indicates whether the most frequent IG in a given latent protein is
represented by less than 30% of the IGs assigned to it. The top bar shows
in dark the 82 latent proteins that match their initial annotation. For most
latent proteins, the most frequent IG has an important contribution and no
latent protein has IGs from more than 17 different labels.
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Fig. 4. Protein identification and status classification. After model fitting, each latent
protein contains a set of peptides, not all of which are from the same protein. (a) Number
of members or protein labels per latent protein. Each column is a different latent protein.
For a particular column, each row contains membership information, ordered top to bottom
from most to least common for the corresponding latent protein. Color encodes member
dominance, thus, dark green indicates that a given latent protein is dominated by peptides
annotated by protein prophet as originating from a single protein. The red line separates
latent proteins in which the leading member has a proportion less than 30%. The top bar
shows in dark the 82 proteins whose posterior label matches prior information. (b) Classi-
fication accuracy presented as AUC values estimated using leave-one-out cross-validation.
Markers indicate median values and error bars cover 90% credible intervals.
7.2. Association with phenotype and pathway analysis. We can also use
latent proteins as predictors of the symptomatic vs. asymptomatic status of
each observation in the data set. For this purpose, we fit individual linear
discriminant classifiers for each latent protein at each MCMC draw and es-
timate the classification accuracy as the area under the ROC curve [AUC,
Receiver Operating Characteristic, Fawcett (2006)]. Figure 4(b) shows re-
sults for the six most discriminant latent proteins: FHR1-H, ZPI-H, CRP-H,
LBP-H, A2GL-H and CO9-H; It shows in particular that FHR1-H has an overall
decent performance. In addition, when treating H1N1 and H3N2 as sep-
arate classification tasks, we observe that H3N2 is clearly easier to clas-
sify.
We also applied the model for protein quantitation of Karpievitch et al.
(2009) using symptomatic/asymptomatic status as a grouping variable. Their
model found 40 significant proteins with q-value threshold 0.05, which is
quite a large number considering the total number of proteins in the data
set is 106. In addition, almost none of these show significant association
with the biological phenotype. We found only 3 proteins in common (CHLE-
H, FHR1-H and HRG-H) when comparing their list to our own. For our model we
used t-tests, q-values and the same 0.05 threshold to be fair with the other
method. However, their list does not include ZPI-H, CRP-H, LBP-H, A2GL-H
or CO9-H, all of which are strongly associated with the symptomatic versus
asymptotic designation.
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Fig. 5. GO scaled log Bayes factors. (a) Latent proteins. (b) Tree nodes. (c) Bayes factors
vs tree nodes for LPT (circles) and RNP (solid line). Shaded area covers 90% empirical
quantiles for RNP values.
As described in Section 3, the prior distribution for the set of latent
proteins allows us to build a binary tree representation of its elements in a
hierarchical clustering fashion. When examining the resulting structure [see
Henao et al. (2013a)] we found some straightforward groupings in the tree
mostly corresponding to protein variants like APOC2-H and APOC3-H, CO8A-H,
CO8B-H and CO8G-H, FIBG-H and FIBB-H, F13A-H and F13B-H, etc., all of them
having similar profiles when looking at their estimated signatures (results
not shown), in other cases, for instance, CO4(a,b)-H and APOB-H, showing great
diversity in their profiles and as a result rather spread in the structure.
In an attempt to quantify whether the latent proteins and tree represen-
tation produced by our model is meaningful from a biological point of view,
we performed Gene Ontology (GO) searches for the protein lists encoded
by each latent protein and each tree node. In order to quantify the strength
of the association between GO annotations and our protein lists, we use
Bayes factors [GATHER, Chang and Nevins (2006)]. As controls we gener-
ated (i) 500 latent proteins/trees from the prior in (3.2) (RND) and (ii) 500
random label permutations for the latent proteins and tree produced by our
model (RNP). Figure 5(a) and (b) shows separate Bayes factor boxplots for
latent proteins and tree nodes, respectively. Bayes factors have been scaled
by the size of the protein list to compensate for the agglomerative mecha-
nism of the tree structure. Differences in medians between LPT and the two
controls are significant with p-value threshold 0.01 for both latent proteins
and tree nodes. Provided that LPT and RNP have the same tree structure,
we can directly compare Bayes factors at each node of the tree. Figure 5(c)
shows scaled Bayes factors for each tree node of LPT (circles) and RNP (me-
dian: solid line; shade: 90% empirical quantiles). We see quite a few nodes
with Bayes factors far exceeding the domain of randomly permuted protein
labels. These nodes are the ones with a high level of evidence for association
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Fig. 6. Discriminant subtree. This figure shows a set of three internal nodes and four
leaves from the latent protein tree structure. Each node is represented as a scatter plot
showing samples (dots) from the H3N2 study. The vertical dotted line separates asymp-
tomatic (left) and symptomatic (right) samples. Samples are grouped along the x-axis
according to time stamp: green for t= 0 (closest to dashed line), yellow for t= 0.2, red for
t= 0.8 and purple for t= 1 (farthest toward the outside edge). The y-axis is the estimated
latent/protein pathway expression. The mean for each group and time point is denoted
with a square. For this group of latent proteins, the symptomatic subjects at time points
t= 0.8 and t= 1 show clear separation.
with the GO annotations complement activation, immune response, acute-
phase response, cytolysis and response to pathogen. The node with largest
Bayes factor [node 30 in Figure 5(c)] contains CRP-H and LBP-H, two of our
most predictive latent proteins.
Figure 6 shows the subtree corresponding to 4 of the discriminant proteins
from Figure 4(b) along with a scatter of the expression values of each latent
protein. Each panel in the figure shows expression in the y-axis and data
grouping in the x-axis. Data to the left-hand side of the dashed vertical
line corresponds to the asymptomatic set, whereas the other side contains
symptomatic observations. Each side is further grouped according to time,
so points closer to the dashed vertical line are for t= 0 (green), then t= 0.2
(yellow), t = 0.8 (red) and the farthest to the outside is t = 1 (purple).
The good separation of observations from times t = {0.8,1} is the feature
responsible for the classification results shown in Figure 4(b). The node
above CRP-H and LBP-H in Figure 6 is node 30 in Figure 5(c).
It should be noted that the DARPA study collected samples from multiple
other sources, and that there is published, publicly available gene expression
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data from the peripheral blood of the same patients we have examined here.
That data is analyzed in Zaas et al. (2009) and a time course trajectory
model is developed on a more complete version of the data in Chen et al.
(2011). Together with the proteomics data included in the supplementary
material [Henao et al. (2013b)], these offer interesting possibilities for fu-
ture work into jointly modeling proteomics and gene expression data. We
have briefly examined the correlation between protein and matched gene
expression in these data sets, but find that it is generally quite low. How-
ever, an examination of the top genes discovered in Zaas et al. (2009) and
the five discriminative proteins elucidated here shows a high overlap in as-
sociated pathways. We suspect that a comprehensive joint analysis of these
data is complicated by the tissue of origin. Specifically, it is not clear that
the proteins in blood plasma originate from peripheral blood mononuclear
cells (from which there is published gene expression data). Instead, it is
likely that much of the observed protein expression is due to activities in
organs such as the liver or kidneys and from the endothelial lining of blood
vessels.
8. Concluding remarks. We have presented a factor model specifically
designed for proteomics data analysis. It successfully handles broad scale
variability that is known to come from technical sources (such as batch ef-
fects and isotope group specific noise), hence enabling us to estimate latent
protein profiles that better describe biological variability. Our hierarchical
representation of isotope groups, latent proteins and protein pathways pro-
vides us with detailed annotation uncertainty assessment, detection of pos-
sibly inaccurately annotated isotope groups and clustering of proteins with
similar expression profiles that reflect biologically related interactions. We
have also shown that features of our model can be used to define predictive
models based either on latent proteins or groups of latent proteins.
APPENDIX: MCMC INFERENCE DETAILS
We describe next the MCMC analysis mostly based on Gibbs sampling.
We provide then the relevant conditional posteriors and SMC-based update
details for the tree structure. To simplify notation, we use the following
shorthands. Let Xm = [xm1 · · · x
m
Nm
] and X = [X1 · · · XNB ], where NB
is the number of batches, Nm is the number of samples in batch m and
N =
∑NB
m=1Nm. Define 1k to be a k-dimensional row vector of ones and
let X˜ be the full data set with the appropriate means subtracted off; this
is X˜= [X1−µ11N1 · · · X
NB −µNB1KNB ], and Z= [z1 · · · zN ] andW=
[w1 · · · wN ], systematic factors and latent protein matrices of sizes NF ×N
and NP ×N , respectively. For any matrix M, defineMi: as its ith row and
M:j to be its jth column.
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Noise variance. Sample each element of the diagonal of Ψ from
ψ−1i |ts, tr ∼Gamma
(
ts +
N
2
, tr + c
)
,
where ts and tr are, respectively, prior shape and rate and
c= 12(X˜i: −Ai:Z−Bi:W)(X˜i: −Ai:Z−Bi:W)
⊤.
Batch means. Sample mean vector for batch m from
µ
m|tm, tp ∼N
(
C
(
tmtp +Ψ
−1
Nm∑
n=1
x
m
n −Azn −Bwn
)
,C
)
,
where C= (tp +NmΨ
−1)−1, tm and tp are prior mean and precision.
Systematic effect factors. The conditional posterior of Z, using a scale
mixture of Gaussian representation, can be computed independently for each
element of the matrix using
zjn|τjn ∼N (cjnA
⊤
:jΨ
−1
ε\jn, cjn),
where cjn = (A
⊤
:jΨ
−1
A:j+τ
−1
jn )
−1 and ε\jn = xn−Azn−Bwn−µ
m|zjn = 0.
The mixing variances τjn are exponentially distributed with rate λ
2, hence,
their resulting conditional posterior is
τ−1jn |λ
2 ∼ IG
(√
λ2
zjn
, λ2
)
, λ2|ℓs, ℓr ∼Gamma
(
ℓs +
1
2
, ℓr +
1
2
∑
j,n
τjn
)
,
where ℓs and ℓr are shape and rate priors, respectively. IG(·|µ,λ) is the
inverse Gaussian distribution with mean µ and scale λ [Chhikara and Folks
(1989)]. Each element aij from the loading matrix A is sampled from
aij ∼N (cijε\ijZ
⊤
l: , cijψi),
where cij = (Zj:Z
⊤
j: + ψiρj)
−1 and ε\ij = X˜i: −Ai:Z−Bi:W|aij = 0. Then,
column-wise precisions for A are drawn from
ρj|rs, rr ∼Gamma
(
rs +
p
2
, rr +
∑
i
a2ij
)
,
where rs and rr are prior shape and rate, respectively.
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Protein profiles. The conditional posterior for latent proteinsW can be
updated from
Wk:|vk ∼N (CB
⊤
:kΨ
−1(X˜−AZ) +CS−1k mk,C),
where C= (B⊤:kΨ
−1
B:k +S
−1
k )
−1, with mk and Sk being mean and covari-
ance of the parent profile vk ofWk:. Note that bik = 0 for all isotope groups
not assumed to be part of this protein, and that these will not contribute
to the update distribution for Wk:. Besides,
bik|bik 6= 0∼N+(c(X˜i: −Ai:Z)W
⊤
k:, cψi),
where c = (Wk:W
⊤
k: + ψi)
−1 and N+(·) is the Gaussian distribution trun-
cated below zero. Now we can sample IG-latent protein assignments from
ui|α,κ, ts, tr ∼Discrete(vi),
vk ∝ (α+ nk)c
−1/2(tr +
1
2X˜i:X˜
⊤
i: −
1
2c
−1
X˜i:W
⊤
k:Wk:X˜
⊤
i: )
−(ts+N/2),
where nk is the number of nonzero entries in column k of B, c=Wk:W
⊤
k:
and vk is the kth element of vi.
Protein pathway expression and tree structure. We sample the tree
structure components t, pi and Φ, and the means and covariances of each
internal node of the tree, mk and Sk, respectively, using the SMC sampler
described in Henao and Lucas (2012). In particular, {t,pi} are obtained for
a numberM of particles, as a leaves to root SMC pass, together with partial
updates of the node parameters {mk,Sk}. Next we use the particle’s weights
to sample a single configuration. The procedure is completed by resampling
the hyperparameters of the covariance function and by completing the up-
dates of the node parameters using the selected configuration, the latter as
a root to leaves pass.
Missing values. For each missing value xmin corresponding to isotope
group i, sample n and batch m, we simply use independent standardized
Gaussian prior distributions.
Initialization. We start the model from maximum likelihood estimates of
the less critical quantities, that is, batch means {µm}NBm=1 and noise variances
Ψ. Systematic factors Z and latent proteins W are initialized using stan-
dardized Gaussian distributions. The loading matrices A and B (nonzero
elements only) were set to ordinary least squares estimates based upon al-
ready set Z and W, respectively. The vector of associations u was set with
the information obtained from annotation about IG-protein assignments.
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SUPPLEMENTARY MATERIAL
Tree structure (DOI: 10.1214/13-AOAS639SUPPA; .eps). Figure showing
the tree structure for the H1N1/H3N2 viral challenge data.
Data (DOI: 10.1214/13-AOAS639SUPPB; .zip). H1N1/H3N2 viral chal-
lenge raw data.
Estimated proteins (DOI: 10.1214/13-AOAS639SUPPC; .pdf). Figures
showing the estimated proteins for the spike-in data experiment.
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